Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Mason

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Journal of Oncology|December 21, 2020
Corrigendum to "Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease"Guangzhi Zhang, Kiandokht Bashiri, Mark Kneteman, et al.
Canadian Liver Journal|August 22, 2022
Serum IgG4 cut-off of 70 mg/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patientsFarhad Peerani, Lillian Du, Ellina Lytvyak, et al.
Journal of Oncology|May 16, 2020
Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver DiseaseGuangzhi Zhang, Kiandokht Bashiri, Mark Kneteman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2012
Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantationAldo J Montano-Loza, Florencia Vargas-Vorackova, Mang Ma, et al.
International Journal of Molecular Sciences|August 12, 2023
Evidence of a Novel Mitochondrial Signature in Systemic Sclerosis Patients with Chronic Fatigue SyndromeCharmaine van Eeden, Desiree Redmond, Naima Mohazab, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 20, 2003
Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?George E Loss, Andrew L Mason, Satheesh Nair, et al.
Frontiers in Microbiology|August 8, 2020
Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) MutantsKeith C K Lau, Shivali S Joshi, Douglas J Mahoney, et al.
Canadian Journal of Gastroenterology & Hepatology|July 22, 2015
Time to make the change from 'primary biliary cirrhosis' to 'primary biliary cholangitis'Angela C Cheung, Aldo Montano-Loza, Mark Swain, et al.
Frontiers in Cellular and Infection Microbiology|January 24, 2017
Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNAJuan Jovel, Sandra O'keefe, Jordan Patterson, et al.
Marine Pollution Bulletin|January 15, 2008
Chemical contamination in southwest Puerto Rico: an assessment of organic contaminants in nearshore sedimentsAnthony S Pait, David R Whitall, Christopher F G Jeffrey, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Journal of Oncology|December 21, 2020
Corrigendum to "Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease"Guangzhi Zhang, Kiandokht Bashiri, Mark Kneteman, et al.
Canadian Liver Journal|August 22, 2022
Serum IgG4 cut-off of 70 mg/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patientsFarhad Peerani, Lillian Du, Ellina Lytvyak, et al.
Journal of Oncology|May 16, 2020
Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver DiseaseGuangzhi Zhang, Kiandokht Bashiri, Mark Kneteman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2012
Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantationAldo J Montano-Loza, Florencia Vargas-Vorackova, Mang Ma, et al.
International Journal of Molecular Sciences|August 12, 2023
Evidence of a Novel Mitochondrial Signature in Systemic Sclerosis Patients with Chronic Fatigue SyndromeCharmaine van Eeden, Desiree Redmond, Naima Mohazab, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 20, 2003
Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?George E Loss, Andrew L Mason, Satheesh Nair, et al.
Frontiers in Microbiology|August 8, 2020
Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) MutantsKeith C K Lau, Shivali S Joshi, Douglas J Mahoney, et al.
Canadian Journal of Gastroenterology & Hepatology|July 22, 2015
Time to make the change from 'primary biliary cirrhosis' to 'primary biliary cholangitis'Angela C Cheung, Aldo Montano-Loza, Mark Swain, et al.
Frontiers in Cellular and Infection Microbiology|January 24, 2017
Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNAJuan Jovel, Sandra O'keefe, Jordan Patterson, et al.
Marine Pollution Bulletin|January 15, 2008
Chemical contamination in southwest Puerto Rico: an assessment of organic contaminants in nearshore sedimentsAnthony S Pait, David R Whitall, Christopher F G Jeffrey, et al.
Pageof 11